SCHEMBL4972971

SCHEMBL4972971

CCC(OC(C)=O)(c1ccccc1)C(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.44
OPRM1 P35372 4/20 0.44
OPRD1 P41143 3/20 0.44
MRGPRX2 Q96LB1 2/20 0.44
OPRK1 P41145 2/20 0.44
CHRM3 P20309 1/20 0.44
HRH2 P25021 1/20 0.44
HTR2A P28223 1/20 0.44
ADRA1A P35348 1/20 0.44
CYP1A2 P05177 2/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C19 P33261 2/20 0.42
HIF1A Q16665 1/20 0.42
KIF11 P52732 2/20 0.39
GRIN2D O15399 2/20 0.39
GRIN1 Q05586 2/20 0.39
GRIN2A Q12879 2/20 0.39
GRIN2B Q13224 2/20 0.39
GRIN2C Q14957 2/20 0.39
CACNA1F O60840 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4638235 0.85 KIF11 (0.39) KCNH2OPRM1OPRD1MRGPRX2OPRK1
SCHEMBL5861679 0.84 KIF11 (0.38) KCNH2OPRM1OPRD1MRGPRX2OPRK1
SCHEMBL489171 0.78 CNR1 (0.35) KCNH2OPRM1OPRD1MRGPRX2OPRK1
SCHEMBL21401129 0.78 KCNH2 (0.38) KCNH2OPRM1OPRD1MRGPRX2OPRK1
SCHEMBL10234508 0.77 CYP2C19 (0.46) KCNH2OPRM1CHRM3CYP1A2CYP2D6
SCHEMBL28042748 0.77 KCNH2 (0.38) KCNH2OPRM1OPRD1MRGPRX2OPRK1
SCHEMBL21742050 0.76 SMN1; SMN2 (0.40) KCNH2OPRK1ADRA1ACYP1A2CYP2D6
SCHEMBL18408916 0.75 CYP2C19 (0.48) KCNH2CHRM3CYP1A2CYP2D6CYP2C19
SCHEMBL5571854 0.75 CYP2C19 (0.48) KCNH2CHRM3CYP1A2CYP2D6CYP2C19
SCHEMBL10939163 0.74 KCNH2 (0.44) KCNH2OPRM1OPRD1MRGPRX2OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018145219-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING SERANI MOSTAZAL JORGE (CL) 2018-08-16 WO claimed
EP-1979301-A1 PERFUMING INGREDIENTS WITH ODOR OF THE PHEROMONE TYPE FIRMENICH SA (CH) 2008-10-15 EP disclosed
WO-2007085984-A1 PERFUMING INGREDIENTS WITH ODOR OF THE PHEROMONE TYPE FIRMENICH SA (CH) 2007-08-02 WO disclosed